Aileron Therapeutics Inc (ALRN) has released an update.
Aileron Therapeutics, Inc. has issued a Current Report on Form 8-K to provide updates on the company’s information, with capitalized terms retaining their meanings as defined in the preliminary proxy statement filed earlier with the Securities and Exchange Commission.
For further insights into ALRN stock, check out TipRanks’ Stock Analysis page.